Covista Inc.

Covista Inc.

CVSANYSE / NASDAQConsumer DefensiveMid cap

$109.13-$6.38 (-5.5%)

Last close · Data as of Nov 20, 2026

Market cap
$4.2B
P/E
17.9x
EV / EBITDA
11.3x
Revenue
$1.8B
Net margin
13.3%
ROCE
15.4%

+16.4% over the last year

Covista Inc. price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
-14.5%
3M
-14.8%
6M
-13.4%
1Y
+16.4%
5Y
+256.5%

52-week range

Day change -$6.38 (-5.5%) from $116 to $109 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in CVSA, bought on each weekday since 2021.

News & filings

What Covista filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

StrengthOperating margin of 19.3% against a peer median of 15.5%.

Concerns (1)

  • Current assets are 0.82 times current liabilities.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary.

Read moreShow less

Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary. The company offers degree and non-degree programs, including bachelor's, master's, and doctoral degrees; and online certificate programs for nursing, health professions, medical, and veterinary postsecondary education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. It also operates Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as Adtalem Global Education Inc. and changed its name to Covista Inc. in February 2026. Covista Inc. was incorporated in 1987 and is headquartered in Chicago, Illinois.

Sector
Consumer Defensive
Shares outstanding
37.1M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$4.2B
P/E
17.9x
P/B
3.0x
EV / EBITDA
11.3x
EV / Sales
2.7x
P/S
2.4x
52-week high
$140.98
52-week low
$89.36

Profitability

Operating margin
19.3%
Net margin
13.3%
EBITDA margin
23.9%
ROE
16.5%
ROCE
15.4%
ROA
8.6%
Asset turnover
0.65

Growth

Revenue
$1.8B
Revenue growth, 1Y
12.9%
Revenue CAGR, 3Y
9.0%
Net profit growth, 1Y
73.3%
Free cash flow
$287.6M

Solvency

Current ratio
0.82
Debt / Equity
0.54
Debt / Assets
0.28
CFO / Net profit
1.43
Cash / Market cap
4.7%

Where the revenue went

Of every $100 of FY2025 revenue, $13 was left as net income.

Covista Inc. income statement flow, FY2025
Covista Inc. income statement flow, FY2025: flows
FromToAmount
RevenueCost of revenue$771.4M
RevenueGross profit$1.0B
Gross profitSelling, general and administrative$672.0M
Gross profitOperating income$344.9M
Operating incomePretax income$298.5M
Operating incomeInterest and other expense$46.4M
Pretax incomeTax and other$61.4M
Pretax incomeNet income$237.1M

Revenue and net profit

Revenue grew 12.9% in FY2025; net profit is the dashed line.

Covista Inc. revenue and net profit by fiscal year
Covista Inc. revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$1.4B$311.0M
FY2023$1.5B$93.4M
FY2024$1.6B$136.8M
FY2025$1.8B$237.1M

Cash flows

FY2025: $337.9M from operations, $287.6M free after investment (dashed).

Covista Inc. operating and free cash flow by fiscal year
Covista Inc. operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022$10.6M-$20.5M
FY2023$191.9M$165.9M
FY2024$295.8M$246.9M
FY2025$337.9M$287.6M

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$1.8B+12.9%1Y
EBITDA
$427.3M+31.0%1Y
Net profit
$237.1M+73.3%1Y
Cash from operations
$337.9M+14.2%1Y
Free cash flow
$287.6M+16.5%1Y
Revenue CAGR, 3Y
9.0%
Net profit CAGR, 3Y
-8.7%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$1.8B$427.3M$237.1M$287.6M16.5%+12.9%+73.3%

Monthly returns

Month-by-month returns of CVSA across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$2.8B
Liabilities$1.3B
Equity$1.4B
Paid-in capital$664.3M
Retained earnings$2.8B
Treasury stock$2.0B

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Consumer Defensive companies placed by value, growth and quality; CVSA highlighted.

P/E against peers

CVSA trades at 17.9x earnings against a peer median of 17.0x.

Not shown (no positive earnings and no EV / Sales): United Natural Foods, Inc.

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
Covista Inc.CVSAthis company$4.2B17.9x3.0x16.5%11.3x
PriceSmart, Inc.PSMT$5.3B36.2x4.3x11.9%17.8x
Laureate Education, Inc.LAUR$4.7B16.7x4.0x23.7%9.7x
Stride, Inc.LRN$4.3B15.1x2.9x19.5%8.1x
The Vita Coco Company, Inc.COCO$4.2B59.2x12.7x21.5%48.4x
Cal-Maine Foods, Inc.CALM$3.5B2.9x1.4x47.6%1.3x
National Beverage Corp.FIZZ$3.3B17.4x7.3x42.1%12.2x
United Natural Foods, Inc.UNFI$3.2B-27.4x2.1x-7.6%21.7x
The Chefs' Warehouse, Inc.CHEF$3.2B43.7x5.2x12.0%18.0x
Peer median—17.0x4.1x20.5%15.0x

Year-to-date ROI

CVSA since 1 January, against earlier years.

Historical volatility

CVSA's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

Covista Inc. operating margin by fiscal year
Covista Inc. operating margin by fiscal year
DateOperating margin
FY202211.3%
FY202314.9%
FY202416.0%
FY202519.3%
LineFY2025
Cost of revenueCost Of Revenue$771.4M
Gross profitGross Profit$1.0B
Operating expensesOperating Expense$672.0M
Selling, general and administrativeSelling General And Administration$672.0M
Total expensesTotal Expenses$1.4B
Pretax incomePretax Income$298.5M

Learn while you research

Academy chapters picked for Covista Inc. and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Cyclical vs Defensive StocksConsumer staples behave defensively across the business cycle.6 min read
  3. 03 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  4. 04 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →